Home  /  Investors   /  Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 10 out of 31 posts.
16 Dec, 2019
XVIVO Perfusion granted Breakthrough Device Designation from the FDA for the XVIVO Heart Preservation System
Other Corporate Information News IR English Corporate Information
29 Oct, 2019
Third XPS™ sold in Australia
News IR English Corporate Information Other Corporate Information
24 Oct, 2019
Good growth and new important XPS clinics
Report Interim Q3 News IR English Regulatory MAR
23 Oct, 2019
XVIVO opens a subsidiary in Australia
News IR English Corporate Information Other Corporate Information
23 Oct, 2019
XVIVO Perfusion AB (publ) issue of warrants of series 2019/2021 fully subscribed
English Regulatory Listing Regulation Corporate Information Other Corporate Information News IR
21 Oct, 2019
Conference call on Interim Report
News IR English Corporate Information Other Corporate Information
24 Sep, 2019
Nomination Committee of XVIVO Perfusion AB (publ)
IR English Corporate Information Nomination Committee News
18 Sep, 2019
XPS™ sold to China
News IR English Corporate Information Other Corporate Information
23 Aug, 2019
Lung Bioengineering has acquired the XPS™ for use in its new Jacksonville EVLP center
English Corporate Information Other Corporate Information News IR
21 Aug, 2019
Perfadex® Plus has received patent approval in Europe
News IR English Regulatory MAR Corporate Information Other Corporate Information

Fill out the form to watch the video